Fairfield Market Research Drug Delivery Devices Market to Reach US$90.2 Bn by 2033

Drug Delivery Devices Market

Global Drug Delivery Devices Industry Analysis, Size, Share, Growth, Trends, and Forecast 2023-2033 - (By Product Coverage, By Usage Coverage, By Route of Administration Coverage, By Sales Channel Coverage, By Application Coverage, By Geographic Coverage and By Company)

Published Date: Mar 2024 | Format: | No. of Pages: 300

Industry: Medical Devices


Request Sample Request Customization

Global Drug Delivery Devices Market Forecast

  • The approximately US$35.4 Bn market for drug delivery devices (2023) to reach US$90.2 Bn by the end of 2033
  • Between 2023 and 2033, the market is anticipated to expand at a CAGR of 6.2%.

Drug Delivery Devices Market Snapshot, 2018 - 2033

Quick Report Digest

  1. The market is witnessing increased adoption of smart drug delivery devices, driven by patients' desire for control and convenience in healthcare. These devices offer automated dosing, reminders, and data tracking, enhancing medication adherence and enabling remote patient monitoring in telemedicine.
  2. Regulatory challenges, particularly lengthy approval processes by agencies like the US FDA and EMA, hinder market entry and innovation. The prolonged timelines may discourage companies from pursuing novel technologies, limiting the introduction of more effective, patient-friendly, and cost-efficient drug delivery devices.
  3. Needle-free anesthesia and injectors are gaining popularity, especially among pediatric and geriatric populations. The market trend reflects a shift towards painless alternatives, providing a significant demand-side opportunity. Skin properties and optimal injection parameters are crucial considerations for successful implementation.
  4. The US FDA plays a crucial role in regulating medical devices, ensuring safety and effectiveness. Manufacturers face various regulatory controls, including premarket review, labelling, and quality system regulation. Compliance with these standards is essential for the development, approval, and market success of drug delivery devices.
  5. Insulin pens, characterized by user-friendliness and reduced pain, dominate the market. Their portability, ease of handling, and precise dosing collectively contribute to better patient adherence, leading to improved glycemic control. The simplicity of insulin pens facilitates patient compliance and supports individualized dosing.
  6. Disposable drug delivery devices offer convenience and safety, especially in self-administration scenarios. They eliminate the need for cleaning, reducing the potential for medication errors. Advances in prefilled syringes and auto-injectors enhance self-administration, expanding the range of drugs deliverable through these devices.
  7. The rise in biologics and the growing trend of self-administration drive the preference for subcutaneous drug delivery. This method offers a less invasive and comfortable alternative, promoting patient compliance. The demand for devices designed for subcutaneous administration is further propelled by the increasing use of biologics for chronic conditions.
  8. North America leads the market due to the high prevalence of chronic diseases and continuous innovations in drug delivery technologies. The region's focus on technological advancements, robust healthcare infrastructure, and adherence to stringent regulatory standards contribute to the development and adoption of cutting-edge drug delivery devices.
  9. There is a growing emphasis on personalized medicine, requiring specialized drug delivery devices for precise dosages and targeted therapies. Stringent regulatory standards in North America ensure the safety, quality, and efficacy of these devices, fostering market expansion.
  10. Continuous R&D efforts focus on creating novel drug delivery devices, with manufacturers collaborating with pharmaceutical companies, research institutions, and technology firms. These partnerships accelerate product development timelines, expand market reach, and promote the adoption of innovative technologies such as smart devices and wearable systems.

A Look Back and a Look Forward - Comparative Analysis

The drug delivery devices market witnessed steady growth during this period. Advancements in technology, such as the development of novel delivery systems and the rise in biologics usage, contributed significantly to market expansion. The market experienced a surge in demand for devices such as injectable systems, inhalers, and patches.

Moreover, the projection indicates growth in the drug delivery devices market. Factors such as increasing R&D investments, the need for targeted drug delivery systems, and rising demand for self-administration devices were expected to drive market expansion. Technological innovations, including smart drug delivery systems and personalised medicine, were anticipated to further stimulate market growth.

Drug Delivery Devices Market, US$ Bn, 2018 - 2033

Key Growth Determinants

Increasing Use of Smart Molecular Diagnostics

Patients increasingly seek more control and convenience in their healthcare management. Smart drug delivery devices cater to this demand by allowing patients to monitor and administer their medications with greater precision. These devices may include features like automated dosing, reminders, and data tracking, enabling patients to adhere to treatment regimens more effectively.

For healthcare providers, the real-time data generated by smart drug delivery devices facilitates remote monitoring of patients. This feature is particularly significant in telemedicine and remote patient management, as it allows healthcare professionals to adjust treatment plans promptly and ensure medication adherence.

The demand for smart drug delivery devices is further fuelled by the pharmaceutical industry's interest in developing and marketing digital therapeutics. By integrating drug delivery with technology, pharmaceutical companies can provide a more holistic approach to treatment, combining medication with data-driven insights and support for patients.

Major Growth Barriers

Regulatory Hurdles

One of the important issues arising from regulatory hurdles is the time-consuming process of gaining approvals. Regulatory agencies, such as the US FDA, and the European Medicines Agency (EMA), demand comprehensive clinical trials, extensive documentation, and rigorous testing to evaluate the performance, safety, and efficacy of drug delivery devices.

The approval process can stretch over several years, delaying market entry and driving up development costs. This extended timeline can be particularly frustrating for companies eager to capitalize on new technologies or address emerging medical needs promptly.

Another notable impact of regulatory hurdles is the potential stifling of innovation.

Companies may be discouraged from pursuing novel and groundbreaking drug delivery technologies due to the fear of the lengthy and uncertain approval process. This can deter investment in research and development, limiting the introduction of more effective, patient-friendly, and cost-efficient devices.

Key Trends and Opportunities to Look at

Growing demand for Pain-free and Needle-free Delivery

Needle free anaesthesia is an innovative solution that has transformed the way we think about pain management. It offers a safe, effective, and pain-free alternative to traditional anaesthesia delivery methods, and it has the potential to revolutionize the medical industry in the years to come.

According to Clinical, Cosmetic and Investigational Dermatology Journal, needleless injectors not only reduce pain during drug delivery but also confine the drug more evenly in the dermis. Understanding skin properties of the injection site is a key factor to obtain optimal results as well as setting the right parameters of the jet injector.

Therefore, the growing demand for pain-free and needle-free drug delivery represents a significant demand-side trend in the drug delivery devices market. Patients, particularly in paediatric and geriatric demographics, are increasingly seeking painless alternatives to traditional injection methods.

Drug Delivery Devices Market, DROs

How Does the Regulatory Scenario Shape this Industry?

Medical devices are an important part of healthcare service delivery, and developments in new technologies can improve their ability to diagnose and treat illness. The US FDA, an agency within the Department of Health and Human Services (HHS), is responsible for regulating the safety and effectiveness of medical devices. The US FDA’s Center for Devices and Radiological Health (CDRH) is primarily responsible for medical device regulation, with assistance from the Center for Biologics Evaluation and Research (CBER).

Medical device manufacturers are subject to a range of regulatory controls (i.e., requirements) to ensure that devices are not adulterated or misbranded and to otherwise assure their safety and effectiveness for their intended use. These requirements include, for example, premarket review, labelling, establishment registration and device listing, and quality system regulation (good manufacturing practices for devices).

Fairfield’s Ranking Board

Convenience and Ease of Use Secure the Bestselling Potential of Insulin Pens

Insulin pens are user-friendly and offer a convenient way for diabetic patients to self-administer insulin. They are portable, discreet, and simpler to handle compared to vials and syringes, making them more appealing to patients. The ease of use and reduced pain associated with insulin pens often lead to better patient adherence to prescribed insulin regimens.

Patients are more likely to comply with their treatment plans due to the simplicity of using insulin pens, contributing to improved glycemic control. Insulin pens provide precise and accurate dosing, allowing patients to administer insulin more accurately compared to traditional methods. They also offer dosing flexibility, enabling users to adjust doses more easily according to individual needs.

Disposable Drug Delivery Devices to be at the Forefront

Disposable devices often provide greater convenience, especially in self-administration scenarios. They are easy to use, eliminating the need for cleaning or sterilisation between uses. This simplicity increases patient compliance and accessibility to treatments. Single-use disposable devices minimize the potential for medication errors that can occur when devices are reused or not adequately cleaned. This contributes to improved patient safety, and treatment effectiveness.

The development of novel disposable devices has facilitated the advancement of drug delivery systems. For instance, advancements in prefilled syringes and auto-injectors have made self-administration of complex medications easier, expanding the range of drugs that can be delivered through these devices.

Subcutaneous Delivery Route Preferred Due to Rise in Biologics, and Growing Need for Self-administration

Subcutaneous drug delivery offers a less invasive and often more comfortable method for patients compared to other routes like intravenous or intramuscular injections. This factor promotes patient compliance with prescribed treatments, thereby driving the demand for devices designed for subcutaneous administration. Many biologic drugs, including monoclonal antibodies and certain protein-based therapies, require subcutaneous delivery.

The increasing use of biologics for chronic conditions like rheumatoid arthritis, diabetes, and autoimmune disorders has propelled the demand for devices specifically designed for subcutaneous injections. Additionally, the trend toward self-administration of medications at home by patients has driven the need for user-friendly subcutaneous delivery devices.

Regional Frontrunners

North America Stands Strong Owing to the Highest Prevalence Rate(s) of Chronic Diseases

North America faces an increasing burden of chronic diseases such as diabetes, cardiovascular diseases, cancer, and respiratory disorders. The need for effective and targeted drug delivery systems to manage these conditions has driven the demand for advanced drug delivery devices in the region.

Continuous innovations in drug delivery technologies, including the development of novel delivery systems, smart devices, and biocompatible materials, have contributed to the growth of the market. North America is a hub for technological advancements and investments in healthcare research and development, fostering the development and adoption of cutting-edge drug delivery devices.

Drug Delivery Devices Market Regional Outlook, 2018 - 2033

Emphasis on Personalised Medicine

There's a growing trend toward personalised medicine and targeted drug delivery systems. This approach requires specialised drug delivery devices that enable the administration of precise dosages and targeted therapies, contributing to market expansion.

The region has stringent regulatory standards and robust healthcare infrastructure, encouraging the development and adoption of technologically advanced drug delivery devices. Compliance with these regulations ensures the safety, quality, and efficacy of the devices, boosting consumer confidence and market growth.

North America Drug Delivery Devices Market, by Product, 2018 - 2033, US$ Bn

Fairfield’s Competitive Landscape Analysis

Continuous research and development efforts to create novel drug delivery devices that offer improved efficiency, safety, and patient convenience. Manufacturers invest in innovative technologies such as smart devices, wearable systems, and biocompatible materials to enhance drug delivery.

Collaboration with pharmaceutical companies, research institutions, and technology firms to leverage combined expertise and resources. These partnerships facilitate the development of new drug-device combinations, accelerate product development timelines, and expand market reach.

Who Are the Leaders in The Global Drug Delivery Devices Market Space?

  1. Eli Lilly and Company
  2. Becton Dickinson And Co.
  3. Novo Nordisk
  4. Sanofi
  5. Johnson & Johnson
  6. Roche
  7. Pfizer
  8. AbbVie
  9. Mylan N.V. (Viatris)
  10. Insulet corporation
  11. Medtronic Plc

Significant Company Developments

Partnership & Acquisition

  • In February 2021, Sanofi announced that the company will provide manufacturing support to Pfizer-BioNTech for the production of COVID-19 vaccines. This partnership is aimed at helping accelerate the delivery of COVID-19 vaccines to people around the world.
  • In January 2021, Lilly announced that it had acquired Prevail Therapeutics, a biotechnology company that specializes in gene therapies for neurodegenerative diseases. The acquisition is aimed at strengthening Lilly's pipeline of treatments for conditions like Parkinson's disease and other neurological disorders.

An Expert’s Eye

Demand and Future Growth

Patients are increasingly preferring drug delivery devices that offer convenience, ease of use, and improved comfort. Devices that enable self-administration, reduce pain, and minimize side effects tend to be in high demand. Patient-centric designs, such as smaller needles for injections or wearable devices for continuous drug delivery, are becoming more popular.

Moreover, healthcare providers seek drug delivery devices that streamline treatment procedures, enhance patient adherence, and improve therapeutic outcomes. Devices with features like precise dosing mechanisms, compatibility with various medications, and user-friendly interfaces are favoured.

Understanding and addressing these demand-side perspectives are essential for manufacturers and stakeholders to develop and commercialize drug delivery devices that effectively meet the needs of patients, healthcare providers, and pharmaceutical companies while navigating regulatory requirements and leveraging technological advancements.

Supply Side of the Market

The growing awareness of the environmental impact of drug delivery devices, particularly single-use plastics. Manufacturers are exploring eco-friendly materials, recyclable packaging, and reusable device designs to reduce waste generation and minimize environmental footprint.

Suppliers also, navigate a complex landscape of regulatory requirements and standards governing the development, manufacturing, and commercialisation of drug delivery devices. Compliance with regulations such as those set by the US FDA, and the European Medicines Agency (EMA) in Europe is crucial for market entry and sustained success.

Global Drug Delivery Devices Market Is Segmented as Below:

By Product:

  • Self-Injector
    • Single Chamber Self Injector
    • Dual Chamber Self Injector
  • Needle Free Injectors
    • Pre-Filled Needle Free Injectors
    • Fill-Able Needle Free Injectors
  • Auto-Injectors
    • Pre-Filled Auto-Injector
    • Fill-Able Auto-Injector
  • Wearable Injectors
    • Wearable Patch Injectors
    • Off-body Worn Injectors
  • Insulin Pens
    • Reusable Insulin Pens
    • Disposable Insulin Pens
    • Smart Insulin Pens
  • Implantable Drug Delivery
    • Contraceptive Implants
    • Intravitreal Implants
    • Buprenorphine Subdermal Implant
    • Implantable Infusion Pumps
  • Transdermal Patches
    • Drug in Adhesive Patches
    • Matrix Patches
    • Microneedle Patches
    • Reservoir Patches

By Usage:

  • Disposable Devices
  • Reusable Devices

By Route of Administration:

  • Transdermal
  • Subcutaneous
  • Intramuscular
  • Implantable

By Sales Channel:

  • Hospitals
  • Specialty Clinics
  • Retail Pharmacy Chains
  • Drug Stores
  • Online Sales Channel

By Application:

  • Diabetes
  • Anaphylaxis
  • Rheumatoid Arthritis
  • Cancer
  • Hormonal Therapy
  • Ophthalmology
  • Others

By Geographic Coverage:

  • North America 
    • United States
    • Canada
    • Mexico 
  • Latin America 
    • Brazil
    • Chile
    • Rest of Latin America
  • Europe 
    • Germany
    • Italy
    • France
    • U.K.
    • Spain
    • Benelux
    • Nordic Countries
    • Russia
    • Poland
    • Hungary
    • Balkan & Baltics
    • Rest of Europe 
  • Asia Pacific
    • China
    • Japan
    • South Korea 
    • India
    • Indonesia
    • Malaysia
    • Philippines
    • Thailand
    • Vietnam
    • Australia & New Zealand
    • Rest of Asia Pacific 
  • Middle East & Africa  
    • Kingdom of Saudi Arabia
    • Other GCC Countries
    • Turkey
    • South Africa
    • Other African Union
    • Israel
    • Rest of Middle East and Africa

1. Executive Summary
1.1. Global Drug Delivery Devices Market Snapshot
1.2. Future Projections
1.3. Key Market Trends
1.4. Regional Snapshot, by Value and Volume, 2023
1.5. Analyst Recommendations

2. Market Overview
2.1. Market Definitions and Segmentations
2.2. Market Dynamics
2.2.1. Drivers
2.2.2. Restraints
2.2.3. Market Opportunities
2.2.4. Supply
2.2.5. Demand
2.3. Forecast Factors - Relevance and Impact
2.4. Economic Overview
2.4.1. World Economic Projections

3. Value Added Insights
3.1. Promotional Strategies by Key Players
3.2. New Product Approvals/Launch
3.3. Parent Market Analysis, 2023
3.4. Value Chain Analysis
3.5. Porter’s Five Forces Analysis
3.6. COVID-19 Impact Analysis
3.7. PESTLE Analysis

4. Price Analysis, 2018 - 2023
4.1. Global Average Price Analysis, by Product, US$ Per Unit, 2018 - 2023
4.2. Prominent Factor Affecting Drug Delivery Devices Prices
4.3. Global Average Price Analysis, by Region, US$ Per Unit

5. Global Drug Delivery Devices Market Outlook, 2018 - 2033
5.1. Global Drug Delivery Devices Market Outlook, by Product, Value (US$ Bn) and Volume (Units), 2018 - 2033
5.1.1. Key Highlights
5.1.1.1. Self-Injector
5.1.1.1.1. Single Chamber Self Injector
5.1.1.1.2. Dual Chamber Self Injector
5.1.1.2. Needle-Free Injectors
5.1.1.2.1. Pre-Filled Needle Free Injectors
5.1.1.2.2. Fill-Able Needle Free Injectors
5.1.1.3. Auto-Injectors
5.1.1.3.1. Pre-Filled Auto Injector
5.1.1.3.2. Fill-Able Auto Injector
5.1.1.4. Wearable Injectors
5.1.1.4.1. Wearable Patch Injectors
5.1.1.4.2. Off-body Worn Injectors
5.1.1.5. Insulin Pens
5.1.1.5.1. Reusable Insulin Pens
5.1.1.5.2. Disposable Insulin Pens
5.1.1.5.3. Smart Insulin Pens
5.1.1.6. Implantable Drug Delivery
5.1.1.6.1. Contraceptive Implants
5.1.1.6.2. Intravitreal Implants
5.1.1.6.3. Buprenorphine Subdermal Implant
5.1.1.6.4. Implantable Infusion Pumps
5.1.1.7. Transdermal Patches
5.1.1.7.1. Drug in Adhesive Patches
5.1.1.7.2. Matrix Patches
5.1.1.7.3. Microneedle Patches
5.1.1.7.4. Reservoir Patches
5.2. Global Drug Delivery Devices Market Outlook, by Usage, Value (US$ Bn)
5.2.1. Key Highlights
5.2.1.1. Disposable Devices
5.2.1.2. Reusable Devices
5.3. Global Drug Delivery Devices Market Outlook, by Route of Administration, Value (US$ Bn), 2018 - 2033
5.3.1. Key Highlights
5.3.1.1. Transdermal
5.3.1.2. Subcutaneous
5.3.1.3. Intramuscular
5.3.1.4. Implantable
5.4. Global Drug Delivery Devices Market Outlook, by Sales Channel, Value (US$ Bn), 2018 - 2033
5.4.1. Key Highlights
5.4.1.1. Hospitals
5.4.1.2. Specialty Clinics
5.4.1.3. Retail Pharmacy Chains
5.4.1.4. Drug Stores
5.4.1.5. Online Sales Channel
5.5. Global Drug Delivery Devices Market Outlook, Share Analysis (%) Outlook, by Application, 2023 & 2033
5.5.1. Key Highlights
5.5.1.1. Diabetes
5.5.1.2. Anaphylaxis
5.5.1.3. Rheumatoid Arthritis
5.5.1.4. Cancer
5.5.1.5. Hormonal Therapy
5.5.1.6. Ophthalmology
5.5.1.7. Others
5.6. Global Drug Delivery Devices Market Outlook, by Region, Value (US$ Bn) , 2018 - 2033
5.6.1. Key Highlights
5.6.1.1. North America
5.6.1.2. Latin America
5.6.1.3. Europe
5.6.1.4. Asia Pacific
5.6.1.5. Middle East & Africa

6. North America Drug Delivery Devices Market Outlook, 2018 - 2033
6.1. North America Drug Delivery Devices Market Outlook, by Product, Value (US$ Bn) and Volume (Units), 2018 - 2033
6.1.1. Key Highlights
6.1.1.1. Self-Injector
6.1.1.1.1. Single Chamber Self Injector
6.1.1.1.2. Dual Chamber Self Injector
6.1.1.2. Needle Free Injectors
6.1.1.2.1. Pre-Filled Needle Free Injectors
6.1.1.2.2. Fill-Able Needle Free Injectors
6.1.1.3. Auto Injectors
6.1.1.3.1. Pre-Filled Auto Injector
6.1.1.3.2. Fill-Able Auto Injector
6.1.1.4. Wearable Injectors
6.1.1.4.1. Wearable Patch Injectors
6.1.1.4.2. Off-body Worn Injectors
6.1.1.5. Insulin Pens
6.1.1.5.1. Reusable Insulin Pens
6.1.1.5.2. Disposable Insulin Pens
6.1.1.5.3. Smart Insulin Pens
6.1.1.6. Implantable Drug Delivery
6.1.1.6.1. Contraceptive Implants
6.1.1.6.2. Intravitreal Implants
6.1.1.6.3. Buprenorphine Subdermal Implant
6.1.1.6.4. Implantable Infusion Pumps
6.1.1.7. Transdermal Patches
6.1.1.7.1. Drug in Adhesive Patches
6.1.1.7.2. Matrix Patches
6.1.1.7.3. Microneedle Patches
6.1.1.8. Reservoir Patches
6.2. North America Drug Delivery Devices Market Outlook, by Usage, Value (US$ Bn), 2018 - 2033
6.2.1. Key Highlights
6.2.1.1. Disposable Devices
6.2.1.2. Reusable Devices
6.3. North America Drug Delivery Devices Market Outlook, by Route of Administration, Value (US$ Bn), 2018 - 2033
6.3.1. Key Highlights
6.3.1.1. Transdermal
6.3.1.2. Subcutaneous
6.3.1.3. Intramuscular
6.3.1.4. Implantable
6.4. North America Drug Delivery Devices Market Outlook, by Sales Channel, Value (US$ Bn), 2018 - 2033
6.4.1. Key Highlights
6.4.1.1. Hospitals
6.4.1.2. Specialty Clinics
6.4.1.3. Retail Pharmacy Chains
6.4.1.4. Drug Stores
6.4.1.5. Online Sales Channel
6.5. North America Drug Delivery Devices Market Outlook, by Application, Value (US$ Bn), 2018 - 2033
6.5.1. Key Highlights
6.5.1.1. Diabetes
6.5.1.2. Anaphylaxis
6.5.1.3. Rheumatoid Arthritis
6.5.1.4. Cancer
6.5.1.5. Hormonal Therapy
6.5.1.6. Ophthalmology
6.5.1.7. Others
6.5.2. BPS Analysis/Market Attractiveness Analysis
6.6. North America Drug Delivery Devices Market Share Analysis (%) Outlook, by Country, 2023 & 2033
6.6.1. Key Highlights
6.6.1.1. U.S. Drug Delivery Devices Market Share Analysis (%) Outlook, by Product, 2023 & 2033
6.6.1.2. U.S. Drug Delivery Devices Market Share Analysis (%) Outlook, by Usage, 2023 & 2033
6.6.1.3. U.S. Drug Delivery Devices Market Share Analysis (%) Outlook, by Route of Administration, 2023 & 2033
6.6.1.4. U.S. Drug Delivery Devices Market Share Analysis (%) Outlook, by Sales Channel, 2023 & 2033
6.6.1.5. U.S. Drug Delivery Devices Market Share Analysis (%) Outlook, by Application, 2023 & 2033
6.6.1.6. Canada Drug Delivery Devices Market Share Analysis (%) Outlook, by Product, 2023 & 2033
6.6.1.7. Canada Drug Delivery Devices Market Share Analysis (%) Outlook, by Usage, 2023 & 2033
6.6.1.8. Canada Drug Delivery Devices Market Share Analysis (%) Outlook, by Route of Administration, 2023 & 2033
6.6.1.9. Mexico Drug Delivery Devices Market Share Analysis (%) Outlook, by Product, 2023 & 2033
6.6.1.10. Mexico Drug Delivery Devices Market Share Analysis (%) Outlook, by Usage, 2023 & 2033
6.6.1.11. Mexico Drug Delivery Devices Market Share Analysis (%) Outlook, by Route of Administration, 2023 & 2033
6.6.1.12. Mexico Drug Delivery Devices Market Share Analysis (%) Outlook, by Sales Channel, 2023 & 2033
6.6.1.13. Mexico Drug Delivery Devices Market Share Analysis (%) Outlook, by Application, 2023 & 2033
6.6.2. BPS Analysis/Market Attractiveness Analysis

7. Latin America Drug Delivery Devices Market Outlook, 2018 - 2033
7.1. Latin America Drug Delivery Devices Market Outlook, by Product, Value (US$ Bn) and Volume (Units), 2018 - 2033
7.1.1. Key Highlights
7.1.1.1. Self-Injector
7.1.1.1.1. Single Chamber Self Injector
7.1.1.1.2. Dual Chamber Self Injector
7.1.1.2. Needle Free Injectors
7.1.1.2.1. Pre-Filled Needle Free Injectors
7.1.1.2.2. Fill-Able Needle Free Injectors
7.1.1.3. Auto Injectors
7.1.1.3.1. Pre-Filled Auto Injector
7.1.1.3.2. Fill-Able Auto Injector
7.1.1.4. Wearable Injectors
7.1.1.4.1. Wearable Patch Injectors
7.1.1.4.2. Off-body Worn Injectors
7.1.1.5. Insulin Pens
7.1.1.5.1. Reusable Insulin Pens
7.1.1.5.2. Disposable Insulin Pens
7.1.1.5.3. Smart Insulin Pens
7.1.1.6. Implantable Drug Delivery
7.1.1.6.1. Contraceptive Implants
7.1.1.6.2. Intravitreal Implants
7.1.1.6.3. Buprenorphine Subdermal Implant
7.1.1.6.4. Implantable Infusion Pumps
7.1.1.7. Transdermal Patches
7.1.1.7.1. Drug in Adhesive Patches
7.1.1.7.2. Matrix Patches
7.1.1.7.3. Microneedle Patches
7.1.1.8. Reservoir Patches
7.2. Latin America Drug Delivery Devices Market Outlook, Share Analysis (%) Outlook, by Usage, 2023 & 2033
7.2.1.1. Disposable Devices
7.2.1.2. Reusable Devices
7.3. Latin America Drug Delivery Devices Market Outlook, Share Analysis (%) Outlook, by Route of Administration, 2023 & 2033
7.3.1. Key Highlights
7.3.1.1. Transdermal
7.3.1.2. Subcutaneous
7.3.1.3. Intramuscular
7.3.1.4. Implantable
7.4. Latin America Drug Delivery Devices Market Outlook, Share Analysis (%) Outlook, by Sales Channel, 2023 & 2033
7.4.1. Key Highlights
7.4.1.1. Hospitals
7.4.1.2. Specialty Clinics
7.4.1.3. Retail Pharmacy Chains
7.4.1.4. Drug Stores
7.4.1.5. Online Sales Channel
7.5. Latin America Drug Delivery Devices Market Outlook, Share Analysis (%) Outlook, by Application, 2023 & 2033
7.5.1. Key Highlights
7.5.1.1. Diabetes
7.5.1.2. Anaphylaxis
7.5.1.3. Rheumatoid Arthritis
7.5.1.4. Cancer
7.5.1.5. Hormonal Therapy
7.5.1.6. Ophthalmology
7.5.1.7. Others
7.5.2. BPS Analysis/Market Attractiveness Analysis
7.6. Latin America Drug Delivery Devices Market Outlook, by Country, Value (US$ Bn) and Volume (Units), 2018 - 2033
7.6.1. Key Highlights
7.6.1.1. Brazil Drug Delivery Devices Market Share Analysis (%) Outlook, by Product, 2023 & 2033
7.6.1.2. Brazil Drug Delivery Devices Market Share Analysis (%) Outlook, by Usage, 2023 & 2033
7.6.1.3. Brazil Drug Delivery Devices Market Share Analysis (%) Outlook, by Route of Administration, 2023 & 2033
7.6.1.4. Brazil Drug Delivery Devices Market Share Analysis (%) Outlook, by Sales Channel, 2023 & 2033
7.6.1.5. Brazil Drug Delivery Devices Market Share Analysis (%) Outlook, by Application, 2023 & 2033
7.6.1.6. Chile Drug Delivery Devices Market Share Analysis (%) Outlook, by Product, 2023 & 2033
7.6.1.7. Chile Drug Delivery Devices Market Share Analysis (%) Outlook, by Usage, 2023 & 2033
7.6.1.8. Chile Drug Delivery Devices Market Share Analysis (%) Outlook, by Route of Administration, 2023 & 2033
7.6.1.9. Chile Drug Delivery Devices Market Share Analysis (%) Outlook, by Sales Channel, 2023 & 2033
7.6.1.10. Chile Drug Delivery Devices Market Share Analysis (%) Outlook, by Application, 2023 & 2033
7.6.2. BPS Analysis/Market Attractiveness Analysis

8. Europe Drug Delivery Devices Market Outlook, 2018 - 2033
8.1. Europe Drug Delivery Devices Market Outlook, by Product, Value (US$ Bn) and Volume (Units), 2018 - 2033
8.1.1. Key Highlights
8.1.1.1. Self-Injector
8.1.1.1.1. Single Chamber Self Injector
8.1.1.1.2. Dual Chamber Self Injector
8.1.1.2. Needle Free Injectors
8.1.1.2.1. Pre-Filled Needle Free Injectors
8.1.1.2.2. Fill-Able Needle Free Injectors
8.1.1.3. Auto Injectors
8.1.1.3.1. Pre-Filled Auto Injector
8.1.1.3.2. Fill-Able Auto Injector
8.1.1.4. Wearable Injectors
8.1.1.4.1. Wearable Patch Injectors
8.1.1.4.2. Off-body Worn Injectors
8.1.1.5. Insulin Pens
8.1.1.5.1. Reusable Insulin Pens
8.1.1.5.2. Disposable Insulin Pens
8.1.1.5.3. Smart Insulin Pens
8.1.1.6. Implantable Drug Delivery
8.1.1.6.1. Contraceptive Implants
8.1.1.6.2. Intravitreal Implants
8.1.1.6.3. Buprenorphine Subdermal Implant
8.1.1.6.4. Implantable Infusion Pumps
8.1.1.7. Transdermal Patches
8.1.1.7.1. Drug in Adhesive Patches
8.1.1.7.2. Matrix Patches
8.1.1.7.3. Microneedle Patches
8.1.1.8. Reservoir Patches
8.2. Europe Drug Delivery Devices Market Outlook, Share Analysis (%) Outlook, by Usage, 2023 & 2033
8.2.1. Key Highlights
8.2.1.1. Disposable Devices
8.2.1.2. Reusable Devices
8.3. Europe Drug Delivery Devices Market Outlook, Share Analysis (%) Outlook, by Route of Administration, 2023 & 2033
8.3.1. Key Highlights
8.3.1.1. Transdermal
8.3.1.2. Subcutaneous
8.3.1.3. Intramuscular
8.3.1.4. Implantable
8.4. Europe Drug Delivery Devices Market Outlook, Share Analysis (%) Outlook, by Sales Channel, 2023 & 2033
8.4.1. Key Highlights
8.4.1.1. Hospitals
8.4.1.2. Specialty Clinics
8.4.1.3. Retail Pharmacy Chains
8.4.1.4. Drug Stores
8.4.1.5. Online Sales Channel
8.5. Europe Drug Delivery Devices Market Outlook, Share Analysis (%) Outlook, by Application, 2023 & 2033
8.5.1. Key Highlights
8.5.1.1. Diabetes
8.5.1.2. Anaphylaxis
8.5.1.3. Rheumatoid Arthritis
8.5.1.4. Cancer
8.5.1.5. Hormonal Therapy
8.5.1.6. Ophthalmology
8.5.1.7. Others
8.5.2. BPS Analysis/Market Attractiveness Analysis
8.6. Europe Drug Delivery Devices Market Outlook, by Country, Value (US$ Bn) and Volume (Units), 2018 - 2033
8.6.1. Key Highlights
8.6.1.1. Germany Drug Delivery Devices Market Share Analysis (%) Outlook, by Product, 2023 & 2033
8.6.1.2. Germany Drug Delivery Devices Market Share Analysis (%) Outlook, by Usage, 2023 & 2033
8.6.1.3. Germany Drug Delivery Devices Market Share Analysis (%) Outlook, by Route of Administration, 2023 & 2033
8.6.1.4. Germany Drug Delivery Devices Market Share Analysis (%) Outlook, by Sales Channel, 2023 & 2033
8.6.1.5. Germany Drug Delivery Devices Market Share Analysis (%) Outlook, by Application, 2023 & 2033
8.6.1.6. Italy Drug Delivery Devices Market Share Analysis (%) Outlook, by Product, 2023 & 2033
8.6.1.7. Italy Drug Delivery Devices Market Share Analysis (%) Outlook, by Usage, 2023 & 2033
8.6.1.8. Italy Drug Delivery Devices Market Share Analysis (%) Outlook, by Route of Administration, 2023 & 2033
8.6.1.9. Italy Drug Delivery Devices Market Share Analysis (%) Outlook, by Sales Channel, 2023 & 2033
8.6.1.10. Italy Drug Delivery Devices Market Share Analysis (%) Outlook, by Application, 2023 & 2033
8.6.1.11. France Drug Delivery Devices Market Share Analysis (%) Outlook, by Product, 2023 & 2033
8.6.1.12. France Drug Delivery Devices Market Share Analysis (%) Outlook, by Usage, 2023 & 2033
8.6.1.13. France Drug Delivery Devices Market Share Analysis (%) Outlook, by Route of Administration, 2023 & 2033
8.6.1.14. France Drug Delivery Devices Market Share Analysis (%) Outlook, by Sales Channel, 2023 & 2033
8.6.1.15. France Drug Delivery Devices Market Share Analysis (%) Outlook, by Application, 2023 & 2033
8.6.1.16. U.K. Drug Delivery Devices Market Share Analysis (%) Outlook, by Product, 2023 & 2033
8.6.1.17. U.K. Drug Delivery Devices Market Share Analysis (%) Outlook, by Usage, 2023 & 2033
8.6.1.18. U.K. Drug Delivery Devices Market Share Analysis (%) Outlook, by Route of Administration, 2023 & 2033
8.6.1.19. U.K. Drug Delivery Devices Market Share Analysis (%) Outlook, by Sales Channel, 2023 & 2033
8.6.1.20. U.K. Drug Delivery Devices Market Share Analysis (%) Outlook, by Application, 2023 & 2033
8.6.1.21. Spain Drug Delivery Devices Market Share Analysis (%) Outlook, by Product, 2023 & 2033
8.6.1.22. Spain Drug Delivery Devices Market Share Analysis (%) Outlook, by Usage, 2023 & 2033
8.6.1.23. Spain Drug Delivery Devices Market Share Analysis (%) Outlook, by Route of Administration, 2023 & 2033
8.6.1.24. Spain Drug Delivery Devices Market Share Analysis (%) Outlook, by Sales Channel, 2023 & 2033
8.6.1.25. Spain Drug Delivery Devices Market Share Analysis (%) Outlook, by Application, 2023 & 2033
8.6.1.26. Benelux Drug Delivery Devices Market Share Analysis (%) Outlook, by Product, 2023 & 2033
8.6.1.27. Benelux Drug Delivery Devices Market Share Analysis (%) Outlook, by Usage, 2023 & 2033
8.6.1.28. Benelux Drug Delivery Devices Market Share Analysis (%) Outlook, by Route of Administration, 2023 & 2033
8.6.1.29. Benelux Drug Delivery Devices Market Share Analysis (%) Outlook, by Sales Channel, 2023 & 2033
8.6.1.30. Benelux Drug Delivery Devices Market Share Analysis (%) Outlook, by Application, 2023 & 2033
8.6.1.31. Nordic Countries Drug Delivery Devices Market Share Analysis (%) Outlook, by Product, 2023 & 2033
8.6.1.32. Nordic Countries Drug Delivery Devices Market Share Analysis (%) Outlook, by Usage, 2023 & 2033
8.6.1.33. Nordic Countries Drug Delivery Devices Market Share Analysis (%) Outlook, by Route of Administration, 2023 & 2033
8.6.1.34. Nordic Countries Drug Delivery Devices Market Share Analysis (%) Outlook, by Sales Channel, 2023 & 2033
8.6.1.35. Nordic Countries Drug Delivery Devices Market Share Analysis (%) Outlook, by Application, 2023 & 2033
8.6.1.36. Russia Drug Delivery Devices Market Share Analysis (%) Outlook, by Product, 2023 & 2033
8.6.1.37. Russia Drug Delivery Devices Market Share Analysis (%) Outlook, by Usage, 2023 & 2033
8.6.1.38. Russia Drug Delivery Devices Market Share Analysis (%) Outlook, by Route of Administration, 2023 & 2033
8.6.1.39. Russia Drug Delivery Devices Market Share Analysis (%) Outlook, by Sales Channel, 2023 & 2033
8.6.1.40. Russia Drug Delivery Devices Market Share Analysis (%) Outlook, by Application, 2023 & 2033
8.6.1.41. Poland Drug Delivery Devices Market Share Analysis (%) Outlook, by Product, 2023 & 2033
8.6.1.42. Poland Drug Delivery Devices Market Share Analysis (%) Outlook, by Usage, 2023 & 2033
8.6.1.43. Poland Drug Delivery Devices Market Share Analysis (%) Outlook, by Route of Administration, 2023 & 2033
8.6.1.44. Poland Drug Delivery Devices Market Share Analysis (%) Outlook, by Sales Channel, 2023 & 2033
8.6.1.45. Poland Drug Delivery Devices Market Share Analysis (%) Outlook, by Application, 2023 & 2033
8.6.1.46. Hungary Drug Delivery Devices Market Share Analysis (%) Outlook, by Product, 2023 & 2033
8.6.1.47. Hungary Drug Delivery Devices Market Share Analysis (%) Outlook, by Usage, 2023 & 2033
8.6.1.48. Hungary Drug Delivery Devices Market Share Analysis (%) Outlook, by Route of Administration, 2023 & 2033
8.6.1.49. Hungary Drug Delivery Devices Market Share Analysis (%) Outlook, by Sales Channel, 2023 & 2033
8.6.1.50. Hungary Drug Delivery Devices Market Share Analysis (%) Outlook, by Application, 2023 & 2033
8.6.1.51. Balkan & Baltics Drug Delivery Devices Market Share Analysis (%) Outlook, by Product, 2023 & 2033
8.6.1.52. Balkan & Baltics Drug Delivery Devices Market Share Analysis (%) Outlook, by Usage, 2023 & 2033
8.6.1.53. Balkan & Baltics Drug Delivery Devices Market Share Analysis (%) Outlook, by Route of Administration, 2023 & 2033
8.6.1.54. Balkan & Baltics Drug Delivery Devices Market Share Analysis (%) Outlook, by Sales Channel, 2023 & 2033
8.6.1.55. Balkan & Baltics Drug Delivery Devices Market Share Analysis (%) Outlook, by Application, 2023 & 2033

9. Asia Pacific Drug Delivery Devices Market Outlook, 2018 - 2033
9.1. Asia Pacific Drug Delivery Devices Market Outlook, by Product, Value (US$ Bn) and Volume (Units), 2018 - 2033
9.1.1. Key Highlights
9.1.1.1. Self-Injector
9.1.1.1.1. Single Chamber Self Injector
9.1.1.1.2. Dual Chamber Self Injector
9.1.1.2. Needle Free Injectors
9.1.1.2.1. Pre-Filled Needle Free Injectors
9.1.1.2.2. Fill-Able Needle Free Injectors
9.1.1.3. Auto Injectors
9.1.1.3.1. Pre-Filled Auto Injector
9.1.1.3.2. Fill-Able Auto Injector
9.1.1.4. Wearable Injectors
9.1.1.4.1. Wearable Patch Injectors
9.1.1.4.2. Off-body Worn Injectors
9.1.1.5. Insulin Pens
9.1.1.5.1. Reusable Insulin Pens
9.1.1.5.2. Disposable Insulin Pens
9.1.1.5.3. Smart Insulin Pens
9.1.1.6. Implantable Drug Delivery
9.1.1.6.1. Contraceptive Implants
9.1.1.6.2. Intravitreal Implants
9.1.1.6.3. Buprenorphine Subdermal Implant
9.1.1.6.4. Implantable Infusion Pumps
9.1.1.7. Transdermal Patches
9.1.1.7.1. Drug in Adhesive Patches
9.1.1.7.2. Matrix Patches
9.1.1.7.3. Microneedle Patches
9.1.1.8. Reservoir Patches
9.2. Asia Pacific Drug Delivery Devices Market Outlook, Share Analysis (%) Outlook, by Usage, 2023 & 2033
9.2.1. Key Highlights
9.2.1.1. Disposable Devices
9.2.1.2. Reusable Devices
9.3. Asia Pacific Drug Delivery Devices Market Outlook, Share Analysis (%) Outlook, by Route of Administration, 2023 & 2033
9.3.1. Key Highlights
9.3.1.1. Transdermal
9.3.1.2. Subcutaneous
9.3.1.3. Intramuscular
9.3.1.4. Implantable
9.4. Asia Pacific Drug Delivery Devices Market Outlook, Share Analysis (%) Outlook, by Sales Channel, 2023 & 2033
9.4.1. Key Highlights
9.4.1.1. Hospitals
9.4.1.2. Specialty Clinics
9.4.1.3. Retail Pharmacy Chains
9.4.1.4. Drug Stores
9.4.1.5. Online Sales Channel
9.5. Asia Pacific Drug Delivery Devices Market Outlook, Share Analysis (%) Outlook, by Application, 2023 & 2033
9.5.1. Key Highlights
9.5.1.1. Diabetes
9.5.1.2. Anaphylaxis
9.5.1.3. Rheumatoid Arthritis
9.5.1.4. Cancer
9.5.1.5. Hormonal Therapy
9.5.1.6. Ophthalmology
9.5.1.7. Others
9.5.2. BPS Analysis/Market Attractiveness Analysis
9.6. Asia Pacific Drug Delivery Devices Market Outlook, by Country, Value (US$ Bn) and Volume (Units), 2018 - 2033
9.6.1. Key Highlights
9.6.1.1. China Drug Delivery Devices Market Share Analysis (%) Outlook, by Product, 2023 & 2033
9.6.1.2. China Drug Delivery Devices Market Share Analysis (%) Outlook, by Usage, 2023 & 2033
9.6.1.3. China Drug Delivery Devices Market Share Analysis (%) Outlook, by Route of Administration, 2023 & 2033
9.6.1.4. China Drug Delivery Devices Market Share Analysis (%) Outlook, by Sales Channel, 2023 & 2033
9.6.1.5. China Drug Delivery Devices Market Share Analysis (%) Outlook, by Application, 2023 & 2033
9.6.1.6. Japan Drug Delivery Devices Market Share Analysis (%) Outlook, by Product, 2023 & 2033
9.6.1.7. Japan Drug Delivery Devices Market Share Analysis (%) Outlook, by Usage, 2023 & 2033
9.6.1.8. Japan Drug Delivery Devices Market Share Analysis (%) Outlook, by Route of Administration, 2023 & 2033
9.6.1.9. Japan Drug Delivery Devices Market Share Analysis (%) Outlook, by Sales Channel, 2023 & 2033
9.6.1.10. Japan Drug Delivery Devices Market Share Analysis (%) Outlook, by Application, 2023 & 2033
9.6.1.11. South Korea Drug Delivery Devices Market Share Analysis (%) Outlook, by Product, 2023 & 2033
9.6.1.12. South Korea Drug Delivery Devices Market Share Analysis (%) Outlook, by Usage, 2023 & 2033
9.6.1.13. South Korea Drug Delivery Devices Market Share Analysis (%) Outlook, by Route of Administration, 2023 & 2033
9.6.1.14. South Korea Drug Delivery Devices Market Share Analysis (%) Outlook, by Sales Channel, 2023 & 2033
9.6.1.15. South Korea Drug Delivery Devices Market Share Analysis (%) Outlook, by Application, 2023 & 2033
9.6.1.16. India Drug Delivery Devices Market Share Analysis (%) Outlook, by Product, 2023 & 2033
9.6.1.17. India Drug Delivery Devices Market Share Analysis (%) Outlook, by Usage, 2023 & 2033
9.6.1.18. India Drug Delivery Devices Market Share Analysis (%) Outlook, by Route of Administration, 2023 & 2033
9.6.1.19. India Drug Delivery Devices Market Share Analysis (%) Outlook, by Sales Channel, 2023 & 2033
9.6.1.20. India Drug Delivery Devices Market Share Analysis (%) Outlook, by Application, 2023 & 2033
9.6.1.21. Indonesia Drug Delivery Devices Market Share Analysis (%) Outlook, by Product, 2023 & 2033
9.6.1.22. Indonesia Drug Delivery Devices Market Share Analysis (%) Outlook, by Usage, 2023 & 2033
9.6.1.23. Indonesia Drug Delivery Devices Market Share Analysis (%) Outlook, by Route of Administration, 2023 & 2033
9.6.1.24. Indonesia Drug Delivery Devices Market Share Analysis (%) Outlook, by Sales Channel, 2023 & 2033
9.6.1.25. Indonesia Drug Delivery Devices Market Share Analysis (%) Outlook, by Application, 2023 & 2033
9.6.1.26. Malaysia Drug Delivery Devices Market Share Analysis (%) Outlook, by Product, 2023 & 2033
9.6.1.27. Malaysia Drug Delivery Devices Market Share Analysis (%) Outlook, by Usage, 2023 & 2033
9.6.1.28. Malaysia Drug Delivery Devices Market Share Analysis (%) Outlook, by Route of Administration, 2023 & 2033
9.6.1.29. Malaysia Drug Delivery Devices Market Share Analysis (%) Outlook, by Sales Channel, 2023 & 2033
9.6.1.30. Malaysia Drug Delivery Devices Market Share Analysis (%) Outlook, by Application, 2023 & 2033
9.6.1.31. Philippines Drug Delivery Devices Market Share Analysis (%) Outlook, by Product, 2023 & 2033
9.6.1.32. Philippines Drug Delivery Devices Market Share Analysis (%) Outlook, by Usage, 2023 & 2033
9.6.1.33. Philippines Drug Delivery Devices Market Share Analysis (%) Outlook, by Route of Administration, 2023 & 2033
9.6.1.34. Philippines Drug Delivery Devices Market Share Analysis (%) Outlook, by Sales Channel, 2023 & 2033
9.6.1.35. Philippines Drug Delivery Devices Market Share Analysis (%) Outlook, by Application, 2023 & 2033
9.6.1.36. Thailand Drug Delivery Devices Market Share Analysis (%) Outlook, by Product, 2023 & 2033
9.6.1.37. Thailand Drug Delivery Devices Market Share Analysis (%) Outlook, by Usage, 2023 & 2033
9.6.1.38. Thailand Drug Delivery Devices Market Share Analysis (%) Outlook, by Route of Administration, 2023 & 2033
9.6.1.39. Thailand Drug Delivery Devices Market Share Analysis (%) Outlook, by Sales Channel, 2023 & 2033
9.6.1.40. Thailand Drug Delivery Devices Market Share Analysis (%) Outlook, by Application, 2023 & 2033
9.6.1.41. Vietnam Drug Delivery Devices Market Share Analysis (%) Outlook, by Product, 2023 & 2033
9.6.1.42. Vietnam Drug Delivery Devices Market Share Analysis (%) Outlook, by Usage, 2023 & 2033
9.6.1.43. Vietnam Drug Delivery Devices Market Share Analysis (%) Outlook, by Route of Administration, 2023 & 2033
9.6.1.44. Vietnam Drug Delivery Devices Market Share Analysis (%) Outlook, by Sales Channel, 2023 & 2033
9.6.1.45. Vietnam Drug Delivery Devices Market Share Analysis (%) Outlook, by Application, 2023 & 2033
9.6.1.46. Australia & New Zealand Drug Delivery Devices Market Share Analysis (%) Outlook, by Product, 2023 & 2033
9.6.1.47. Australia & New Zealand Drug Delivery Devices Market Share Analysis (%) Outlook, by Usage, 2023 & 2033
9.6.1.48. Australia & New Zealand Drug Delivery Devices Market Share Analysis (%) Outlook, by Route of Administration, 2023 & 2033
9.6.1.49. Australia & New Zealand Drug Delivery Devices Market Share Analysis (%) Outlook, by Sales Channel, 2023 & 2033
9.6.1.50. Australia & New Zealand Drug Delivery Devices Market Share Analysis (%) Outlook, by Application, 2023 & 2033
9.6.2. BPS Analysis/Market Attractiveness Analysis

10. Middle East & Africa Drug Delivery Devices Market Outlook, 2018 - 2033
10.1. Middle East & Africa Drug Delivery Devices Market Outlook, by Product, Value (US$ Bn) and Volume (Units), 2018 - 2033
10.1.1. Key Highlights
10.1.1.1. Self-Injector
10.1.1.1.1. Single Chamber Self Injector
10.1.1.1.2. Dual Chamber Self Injector
10.1.1.2. Needle Free Injectors
10.1.1.2.1. Pre-Filled Needle Free Injectors
10.1.1.2.2. Fill-Able Needle Free Injectors
10.1.1.3. Auto Injectors
10.1.1.3.1. Pre-Filled Auto Injector
10.1.1.3.2. Fill-Able Auto Injector
10.1.1.4. Wearable Injectors
10.1.1.4.1. Wearable Patch Injectors
10.1.1.4.2. Off-body Worn Injectors
10.1.1.5. Insulin Pens
10.1.1.5.1. Reusable Insulin Pens
10.1.1.5.2. Disposable Insulin Pens
10.1.1.5.3. Smart Insulin Pens
10.1.1.6. Implantable Drug Delivery
10.1.1.6.1. Contraceptive Implants
10.1.1.6.2. Intravitreal Implants
10.1.1.6.3. Buprenorphine Subdermal Implant
10.1.1.6.4. Implantable Infusion Pumps
10.1.1.7. Transdermal Patches
10.1.1.7.1. Drug in Adhesive Patches
10.1.1.7.2. Matrix Patches
10.1.1.7.3. Microneedle Patches
10.1.1.8. Reservoir Patches
10.2. Middle East & Africa Drug Delivery Devices Market Outlook, Share Analysis (%) Outlook, by Usage, 2023 & 2033
10.2.1. Key Highlights
10.2.1.1. Disposable Devices
10.2.1.2. Reusable Devices
10.3. Middle East & Africa Drug Delivery Devices Market Outlook, Share Analysis (%) Outlook, by Route of Administration, 2023 & 2033
10.3.1. Key Highlights
10.3.1.1. Transdermal
10.3.1.2. Subcutaneous
10.3.1.3. Intramuscular
10.3.1.4. Implantable
10.4. Middle East & Africa Drug Delivery Devices Market Outlook, Share Analysis (%) Outlook, by Sales Channel, 2023 & 2033
10.4.1. Key Highlights
10.4.1.1. Hospitals
10.4.1.2. Specialty Clinics
10.4.1.3. Retail Pharmacy Chains
10.4.1.4. Drug Stores
10.4.1.5. Online Sales Channel
10.5. Middle East & Africa Drug Delivery Devices Market Outlook, Share Analysis (%) Outlook, by Application, 2023 & 2033
10.5.1. Key Highlights
10.5.1.1. Diabetes
10.5.1.2. Anaphylaxis
10.5.1.3. Rheumatoid Arthritis
10.5.1.4. Cancer
10.5.1.5. Hormonal Therapy
10.5.1.6. Ophthalmology
10.5.1.7. Others
10.5.2. BPS Analysis/Market Attractiveness Analysis
10.6. Middle East & Africa Drug Delivery Devices Market Outlook, by Country, Value (US$ Bn) and Volume (Units), 2018 - 2033
10.6.1. Key Highlights
10.6.1.1. Kingdom of Saudi Arabia Drug Delivery Devices Market Share Analysis (%) Outlook, by Product, 2023 & 2033
10.6.1.2. Kingdom of Saudi Arabia Drug Delivery Devices Market Share Analysis (%) Outlook, by Usage, 2023 & 2033
10.6.1.3. Kingdom of Saudi Arabia Drug Delivery Devices Market Share Analysis (%) Outlook, by Route of Administration, 2023 & 2033
10.6.1.4. Kingdom of Saudi Arabia Drug Delivery Devices Market Share Analysis (%) Outlook, by Sales Channel, 2023 & 2033
10.6.1.5. Kingdom of Saudi Arabia Drug Delivery Devices Market Share Analysis (%) Outlook, by Application, 2023 & 2033
10.6.1.6. Other GCC Countries Drug Delivery Devices Market Share Analysis (%) Outlook, by Product, 2023 & 2033
10.6.1.7. Other GCC Countries Drug Delivery Devices Market Share Analysis (%) Outlook, by Usage, 2023 & 2033
10.6.1.8. Other GCC Countries Drug Delivery Devices Market Share Analysis (%) Outlook, by Route of Administration, 2023 & 2033
10.6.1.9. Other GCC Countries Drug Delivery Devices Market Share Analysis (%) Outlook, by Sales Channel, 2023 & 2033
10.6.1.10. Other GCC Countries Drug Delivery Devices Market Share Analysis (%) Outlook, by Application, 2023 & 2033
10.6.1.11. Turkey Drug Delivery Devices Market Share Analysis (%) Outlook, by Product, 2023 & 2033
10.6.1.12. Turkey Drug Delivery Devices Market Share Analysis (%) Outlook, by Usage, 2023 & 2033
10.6.1.13. Turkey Drug Delivery Devices Market Share Analysis (%) Outlook, by Route of Administration, 2023 & 2033
10.6.1.14. Turkey Drug Delivery Devices Market Share Analysis (%) Outlook, by Sales Channel, 2023 & 2033
10.6.1.15. Turkey Drug Delivery Devices Market Share Analysis (%) Outlook, by Application, 2023 & 2033
10.6.1.16. South Africa Drug Delivery Devices Market Share Analysis (%) Outlook, by Product, 2023 & 2033
10.6.1.17. South Africa Drug Delivery Devices Market Share Analysis (%) Outlook, by Usage, 2023 & 2033
10.6.1.18. South Africa Drug Delivery Devices Market Share Analysis (%) Outlook, by Route of Administration, 2023 & 2033
10.6.1.19. South Africa Drug Delivery Devices Market Share Analysis (%) Outlook, by Sales Channel, 2023 & 2033
10.6.1.20. South Africa Drug Delivery Devices Market Share Analysis (%) Outlook, by Application, 2023 & 2033
10.6.1.21. Israel Drug Delivery Devices Market Share Analysis (%) Outlook, by Product, 2023 & 2033
10.6.1.22. Israel Drug Delivery Devices Market Share Analysis (%) Outlook, by Usage, 2023 & 2033
10.6.1.23. Israel Drug Delivery Devices Market Share Analysis (%) Outlook, by Route of Administration, 2023 & 2033
10.6.1.24. Israel Drug Delivery Devices Market Share Analysis (%) Outlook, by Sales Channel, 2023 & 2033
10.6.1.25. Israel Drug Delivery Devices Market Share Analysis (%) Outlook, by Application, 2023 & 2033
10.6.1.26. Share Analysis (%) Outlook, by Application, 2023 & 2033
10.6.2. BPS Analysis/Market Attractiveness Analysis

11. Competitive Landscape
11.1. Company Market Share Analysis, 2023
11.2. Competitive Dashboard
11.3. Company Profiles
11.3.1. Eli Lilly and Company
11.3.1.1. Company Overview
11.3.1.2. Product Portfolio
11.3.1.3. Financial Overview
11.3.1.4. Business Strategies and Development
11.3.2. Becton Dickinson And Co.
11.3.2.1. Company Overview
11.3.2.2. Product Portfolio
11.3.2.3. Financial Overview
11.3.2.4. Business Strategies and Development
11.3.3. Novo Nordisk
11.3.3.1. Company Overview
11.3.3.2. Product Portfolio
11.3.3.3. Financial Overview
11.3.3.4. Business Strategies and Development
11.3.4. Sanofi
11.3.4.1. Company Overview
11.3.4.2. Product Portfolio
11.3.4.3. Financial Overview
11.3.4.4. Business Strategies and Development
11.3.5. Johnson & Johnson
11.3.5.1. Company Overview
11.3.5.2. Product Portfolio
11.3.5.3. Financial Overview
11.3.5.4. Business Strategies and Development
11.3.6. Roche
11.3.6.1. Company Overview
11.3.6.2. Product Portfolio
11.3.6.3. Financial Overview
11.3.6.4. Business Strategies and Development
11.3.7. Pfizer
11.3.7.1. Company Overview
11.3.7.2. Product Portfolio
11.3.7.3. Financial Overview
11.3.7.4. Business Strategies and Development
11.3.8. AbbVie
11.3.8.1. Company Overview
11.3.8.2. Product Portfolio
11.3.8.3. Financial Overview
11.3.8.4. Business Strategies and Development
11.3.9. Mylan N.V. (Viatris)
11.3.9.1. Company Overview
11.3.9.2. Product Portfolio
11.3.9.3. Financial Overview
11.3.9.4. Business Strategies and Development
11.3.10. Insulet corporation
11.3.10.1. Company Overview
11.3.10.2. Product Portfolio
11.3.10.3. Financial Overview
11.3.10.4. Business Strategies and Development
11.3.11. Medtronic plc
11.3.11.1. Company Overview
11.3.11.2. Product Portfolio
11.3.11.3. Financial Overview
11.3.11.4. Business Strategies and Development
11.3.12. Others

12. Appendix

12.1. Research Methodology
12.2. Report Assumptions
12.3. Acronyms and Abbreviations

BASE YEAR

HISTORICAL DATA

FORECAST PERIOD

UNITS

2022

 

2018 - 2022

2023 - 2033

Value: US$ Million Volume: Units

 

REPORT FEATURES

DETAILS

By Product

  • Self-Injector
  • Single Chamber Self Injector
  • Dual Chamber Self Injector
  • Needle Free Injectors
  • Pre-Filled Needle Free Injectors
  • Fill-Able Needle Free Injectors
  • Auto Injectors
  • Pre-Filled Auto Injector
  • Fill-Able Auto Injector
  • Wearable Injectors
  • Wearable Patch Injectors
  • Off-body Worn Injectors
  • Insulin Pens
  • Reusable Insulin Pens
  • Disposable Insulin Pens
  • Smart Insulin Pens
  • Implantable Drug Delivery
  • Contraceptive Implants
  • Intravitreal Implants
  • Buprenorphine Subdermal Implant
  • Implantable Infusion Pumps
  • Transdermal Patches
  • Drug in Adhesive Patches
  • Matrix Patches
  • Microneedle Patches
  • Reservoir Patches

By Usage

  • Disposable Devices
  • Reusable Devices

By Route of Administration 

  • Transdermal
  • Subcutaneous
  • Intramuscular
  • Implantable 

By Sales Channel

  • Hospitals 
  • Specialty Clinics
  • Retail Pharmacy Chains
  • Drug Stores
  • Online Sales Channel

By Application

  • Diabetes
  • Anaphylaxis
  • Rheumatoid Arthritis
  • Cancer
  • Hormonal Therapy
  • Ophthalmology
  • Others

Geographic Coverage

  • North America
  • United States
  • Canada
  • Mexico
  • Latin America
  • Brazil
  • Chile
  • Rest of Latin America
  • Europe
  • Germany
  • Italy
  • France
  • U.K.
  • Spain
  • Benelux
  • Nordic Countries
  • Russia
  • Poland
  • Hungary
  • Balkan & Baltics
  • Rest of Europe
  • Asia Pacific
  • China
  • Japan
  • South Korea
  • India
  • Indonesia
  • Malaysia
  • Philippines
  • Thailand
  • Vietnam
  • Australia & New Zealand
  • Rest of Asia Pacific
  • Middle East and Africa
  • Kingdom of Saudi Arabia
  • Other GCC Countries
  • Turkey
  • South Africa
  • Other African Union
  • Israel
  • Rest of Middle East and Africa

Leading Companies

  • Eli Lilly and Company
  • Becton Dickinson And Co.
  • Novo Nordisk
  • Sanofi
  • Johnson & Johnson
  • Roche
  • Pfizer
  • AbbVie
  • Mylan N.V. (Viatris)
  • Insulet corporation
  • Medtronic Plc
  • Others

 Report Highlights 

Key Market Indicators, Market Estimates and Forecast (Value and Volume), Market Dynamics, Regulatory Guidelines, Technological Advancements, COVID-19 Impact Analysis, Product Insights, Usage Insights, Route of Administration Insights, Sales Channel Insights, Application Insights, Regional and Country Insights, Competitive Landscape, Company Profiles

FAQs : Drug Delivery Devices Market

The global drug delivery devices market is anticipated to reach US$90.2 billion by the end of 2033.

The global drug delivery devices market is anticipated to witness a CAGR of 8.3% during the forecast period 2023-2033, up from a value of US$37.9 Bn in 2022.

North America leads the global drug delivery devices market in terms of value and volume. The region will continue to lead its way through the forecast period to reach a value of US$23 billion by 2030.

Insulin pens is anticipated to dominate the global drug delivery devices market with a CAGR of 7.8% during 2023-2033.

Subcutaneous route of administration holds the largest share and is anticipated to grow at a faster CAGR of 5.7% during 2023-2033.

Our Research Methodology

Considering the volatility of business today, traditional approaches to strategizing a game plan can be unfruitful if not detrimental. True ambiguity is no way to determine a forecast. A myriad of predetermined factors must be accounted for such as the degree of risk involved, the magnitude of circumstances, as well as conditions or consequences that are not known or unpredictable. To circumvent binary views that cast uncertainty, the application of market research intelligence to strategically posture, move, and enable actionable outcomes is necessary.

View Methodology
Fairfield Quality assured
Fairfield Confidentiality assured
Fairfield Custom research services